Uveal Melanoma: Biology and Management

ISBN-13: 9783030781163 / Angielski / Miękka / 2021 / 229 str.

Eric H. Bernicker

Spis treści

Molecular Basis of Uveal Melanoma and Emerging Therapeutic Targets.- Clinical/Commercial.- Genetic Testing in UM.- BAP1 Tumor Predisposition Syndrome.- Pathology of Uveal Melanoma.- Epidemiology of Uveal Melanoma and Potential Clusters.- Gene Expression Profiling in the Management of Uveal Melanoma.- Surgical Considerations of Radiation Plaques and Enucleation.- Uveal Melanoma: Imaging.- Radiation Therapy in Ocular Melanoma.- Late Complications of Radiation Therapy in Uveal Melanoma.- Nanoparticles for the Treatment of Uveal Melanoma.- Screening Schedules for Metastatic Disease.- Adjuvant Therapy of Uveal Melanoma Liver-Directed Therapies for Hepatic Metastases.- Systemic Therapy for Metastatic Uveal Melanoma.- Cell Therapy for Uveal Melanoma.

O autorze

Eric H. Bernicker

Cancer Center, Houston Methodist Hospital

6445 Main Street, OPC 24

Houston, Texas 77030

USA

Blurb

This book provides a comprehensive examination of uveal melanoma, a rare neoplasm that carries a very high mortality and whose natural history makes it fairly unique among adult tumors. Split into three sections, this book explores the basic science behind the disease and inherited genetic syndromes that predispose some patients, as well as the pathology and use of gene expression profiling to determine risk of recurrence. It also focuses on the management of the primary tumor in the eye, including surgical intervention and lesion imaging. Elucidating treatment options for metastatic disease, the book reviews chemotherapy agents and immunotherapy approaches, as well as liver-directed therapies, cellular therapies, and various treatments after primary treatment but before the development of metastases.

Uveal Melanoma: Biology and Management is the most up-to-date and comprehensive text devoted solely to this disease and will be useful to medical oncologists, ophthalmologists, radiation therapists, interventional radiologists, pathologists, molecular biologists and immunology researchers, as well as trainees in those fields.